Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Bristol"


25 mentions found


UK house prices end six-month losing streak - Halifax
  + stars: | 2023-11-07 | by ( David Milliken | ) www.reuters.com   time to read: +2 min
Compared with a year earlier, house prices in October were 3.2% lower versus a 4.5% annual decline in September, leaving the average house price at 281,974 pounds ($347,279), nearly 10,000 pounds lower than a year earlier. British house prices surged during the COVID-19 pandemic due to low interest rates, greater demand and temporary tax breaks. Halifax's house price index is still 18% higher than it was in February 2020, despite a 4% fall since its peak in June 2022. Halifax said it expected house prices to fall further this year, with a return to growth in 2025. "The high cost of borrowing alone is not sufficient to trigger the leg down in house prices we predicted," Capital economist Andrew Wishart said.
Persons: Toby Melville, Kim Kinnaird, Huw Pill, BoE, Kinnaird, Andrew Wishart, David Milliken, Sarah Young, Kate Holton, Bernadette Baum Organizations: REUTERS, Halifax, Lloyds Banking Group, The Bank of England, Capital Economics, Thomson Locations: Bristol, Britain, Halifax, British
RICHMOND, Va. (AP) — Voters in Virginia's capital city are deciding Tuesday whether developers can move forward with a proposed $562 million resort casino along Interstate 95. A ballot measure on whether to allow the gambling and entertainment complex is before Richmond voters for a second time, after the city narrowly rejected the proposal two years ago. Many of the anti-casino signs that dotted the city in recent weeks have emphasized the fact that the city already said “no” once before. Boosters estimate the casino will deliver 1,300 permanent jobs, and developers are promising big financial benefits. An agreement with the city calls for a one-time upfront $25.5 million payment if the referendum passes, with another $1 million after financing closes.
Persons: Levar Stoney, , Tierra, Paul Goldman, Goldman, They’re, trashing, ” Goldman Organizations: , Richmond, Richmond Grand, Urban, Kentucky Derby, Democratic Party, Locations: RICHMOND, Va, Virginia's, Richmond, Churchill Downs, Louisville, Tierra Ward, Virginia, Bristol, Portsmouth, Danville, North Carolina, Norfolk
REUTERS/Toby Melville/File Photo Acquire Licensing RightsLONDON, Nov 7 (Reuters) - British house prices ended six months of consecutive falls in October, reflecting a lack of homes being put up for sale, but prices are still lower than a year ago, mortgage lender Halifax said on Tuesday. Halifax, part of Lloyds Banking Group (LLOY.L), said house prices in October were 1.1% higher than the month before, the first increase since March on a seasonally adjusted basis, after a 0.3% monthly drop in September. This is likely to have strengthened prices in the short-term, rather than prices being driven by buyer demand, which remains weak overall," Kim Kinnaird, director of Halifax Mortgages, said. Compared with a year earlier, house prices in October were 3.2% lower versus a 4.5% annual decline in September, leaving the average house price at 281,974 pounds ($347,279), nearly 10,000 pounds lower than a year earlier. Halifax said it expected further falls in house prices, and a return to growth in 2025.
Persons: Toby Melville, Kim Kinnaird, Kinnaird, David Milliken, Sarah Young, Kate Holton Organizations: REUTERS, Halifax, Lloyds Banking Group, Bank of England, Thomson Locations: Bristol, Britain, Halifax
A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo Acquire Licensing RightsNov 6 (Reuters) - Bristol Myers Squibb (BMY.N) has acquired Orum Therapeutics' experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on Monday. The therapy, ORM-6151, which helps degrade a specific protein hard to treat previously, has received the U.S. Food and Drug Administration's (FDA) clearance for an early stage study. The deal includes an upfront payment of $100 million and milestone payments, Orum said, without disclosing further details. Reporting by Khushi Mandowara in Bengaluru; Editing by Dhanya Ann Thoppil and Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.
Persons: Brian Snyder, Orum, Khushi, Dhanya Ann Thoppil Organizations: Bristol Myers Squibb, REUTERS, Orum Therapeutics, U.S . Food, Thomson Locations: Cambridge , Massachusetts, U.S, Bengaluru
[1/5] Actor Nadjma Abshir, 29 year old, performs a scene from the play ‘Desperate Times’, a sell-out comedy presentation by the Somali women's theatre company ‘Side eYe Productions’, at the Rich Mix arts centre in London, Britain, October 25, 2023. Artistic director Hannah Abdule, a civil servant, co-founded Side eYe Productions in 2019 to create opportunities she felt were denied to people like her. As part of its inclusive mission, Side eYe aims to give opportunities to Somali women with little theatrical experience. "Our parents had more of a mentality of survival and that is getting traditional jobs in sciences, teaching," Abshir said. "We've done what we've needed to do and are looking at the things that truly interest us."
Persons: Nadjma Abshir, Hannah McKay, Hannah Abdule, Sabrina Ali, tangles, Amal Abdi, Abshir, Barbara Lewis, Emelia Sithole Organizations: Somali women's, Rich Mix, REUTERS, Edinburgh Fringe, Somali, Somali Arts and Culture, Thomson Locations: Somali, London, Britain, England, Sheffield, Bristol
Britain to invest 300 million pounds in AI supercomputing
  + stars: | 2023-11-01 | by ( ) www.reuters.com   time to read: +2 min
British Prime Minister Rishi Sunak delivers a speech on AI at Royal Society, Carlton House Terrace on October 26, 2023 in London, England. Funding for the "AI Research Resource" will be increased to 300 million pounds ($363.57 million) from a previously announced 100 million pounds, the government said at an AI safety summit aimed at charting a safe way forward for the rapidly evolving technology. "Frontier AI models are becoming exponentially more powerful," British Prime Minister Rishi Sunak said on social media platform X. "This investment will make sure Britain’s scientific talent have the tools they need to make the most advanced models of AI safe." The machines, which will be running from summer next year, will be used to analyse advanced AI models to test safety features, as well as to drive breakthroughs in drug discovery and clean energy, the government said.
Persons: Rishi Sunak, Peter Nicholls, Bristol's, Kylie MacLellan, Kirsten Donovan Organizations: British, Royal Society, Carlton, Terrace, REUTERS, Nvidia, Hewlett Packard Enterprise, Dell, SME, Thomson Locations: London, England, Britain, Cambridge, Bristol
The U.K. government said Wednesday that it will invest £225 million, or $273 million, into an artificial intelligence supercomputer, highlighting the country's ambition to lead in the technology as it races to catch up to the U.S. and China. The University of Bristol will build the supercomputer, called Isambard-AI after the 19th century British engineer Isambard Brunel. The announcement coincided with the first day of the U.K.'s AI safety summit, which is being held in Bletchley Park. The computer will pack 5,448 GH200 Grace Hopper Superchips, powerful AI chips made by U.S. semiconductor giant Nvidia , which specializes in high-performance computing applications. The U.K. government hopes the two combined supercomputers will achieve breakthroughs in fusion energy, health care and climate modeling.
Persons: Isambard Brunel, Grace Hopper Superchips, StackPC Organizations: The University of Bristol, Nvidia, Hewlett Packard Enterprise, American IT, Cambridge, Dell, Intel Locations: China, Bletchley Park, Britain, U.S, American, East Asia
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company's popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers also reiterated its full-year revenue guidance of a low single-digit percentage decline. Bristol Myers said both older and new drug products helped offset the lower sales of Revlimid for the third quarter. Eliquis, which Bristol Myers shares with Pfizer , is among the first ten drugs selected to face price negotiations with the federal Medicare program. Bristol Myers will hold an earnings call with investors at 8 a.m. E.T.
Persons: Revlimid, Bristol Myers, , Eliquis, FactSet, Opdualag Organizations: Bristol Myers Squibb, Bristol, LSEG, Pfizer, FactSet, Therapeutics Locations: Wednesday's
Hasbro earned $1.64 per share excluding items on $1.5 billion in revenue, while analysts polled by LSEG had anticipated $1.70 per share in earnings and revenue at $1.64 billion. Southwest posted $6.53 billion in revenue, while analysts surveyed by LSEG expected $6.57 billion. Bristol-Myers topped earnings expectations and posted revenue that was in line with expectations. ServiceNow — The software stock rose more than 3% after posting stronger-than-expected quarterly results and sharing solid subscription revenue expectations for the current period. UPS – The shipping company saw shares decline 3% premarket following its third quarter earnings report.
Persons: LSEG, Revlimid, Myers, Overstock.com, Hershey, overshadowing, Mattel —, ServiceNow, it's, Silver Lake, , Sarah Min, Tanaya Macheel, Samantha Subin, Lisa Kailai Han, David Paul Morris Organizations: Hasbro, Southwest —, Southwest, Myers, Bristol, Overstock.com, FactSet, Royal Caribbean, Mattel, Wednesday, UPS, Endeavor Group Holdings, Endeavor, Holdings, WWE, UFC, Barclays —, Bank of America, Barclays, underperform, Hasbro Inc, Target Corp, Bloomberg, Getty Locations: Bristol, Nextracker, FactSet, Thursday's premarket, Emeryville , California, U.S
Bristol Myers reported that it earned $4.1 billion, or $2 per share, in the third quarter, down from $4.3 billion, or $1.99 a share, a year earlier. Analysts, on average, had expected earnings per share of $1.76. It now expects earnings per share in the range of $7.50 to $7.65, up from its previous target of $7.35 to $7.65. Chief Operating Officer Chris Boerner is expected to become chief executive of Bristol Myers next month, replacing current CEO Giovanni Caforio. Earlier in October, BMS agreed to buy cancer drugmaker Mirati Therapeutics (MRTX.O) for up to $5.8 billion, in an attempt to diversify its oncology business.
Persons: David Elkins, Bristol Myers, Chris Boerner, Giovanni Caforio, Michael Erman, Sriparna Roy, Leslie Adler Organizations: Bristol Myers Squibb, BMS, Bristol, Therapeutics, Thomson Locations: The New Jersey
UPS — The shipping company saw shares decline 5.9% after releasing its third-quarter earnings report, which showed disappointing revenue. Full-year revenue guidance was also slightly below expectations. Whirlpool — The home appliance company dropped 15.8% on Thursday after Whirlpool issued full year earnings guidance of about $16 per share. Bristol-Myers Squibb — Shares of the drug maker fell 6.2% after the company reported a decline in sales of its popular blood cancer drug, Revlimid, citing generic competition. ServiceNow — The workflow software company jumped 1.6% after posting third-quarter earnings and revenue that beat analyst expectations.
Persons: LSEG, Merck —, Merck, Steven Vondran, Thomas Bartlett, ServiceNow, , Alex Harring, Yun Li, Lisa Kailai Han, Tanaya, Hakyung Kim Organizations: Bunge —, Comcast, UPS, Hasbro, Whirlpool, Bristol, Myers, Merck, Technology, American Tower Corporation, Flex, IBM —, Wall, CNBC Locations: NBCUniversal, American
Morning Bid: Haunted by 5% ahead of ECB, GDP and Amazon
  + stars: | 2023-10-26 | by ( ) www.reuters.com   time to read: +5 min
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2023. With Amazon due to report later, there was no respite for the so-called 'Magnificent Seven' Wall St behemoths or the wider market ahead of Thursday's open. The bond market seemed unimpressed even as the U.S. House of Representatives ended a three week hiatus by electing Republican Mike Johnson, a conservative with little leadership experience, as speaker. European stocks (.STOXXE) and the euro dropped sharply, meantime, as regional banking shares were hit ahead of the European Central Bank's policy decision later in the day. Key developments that should provide more direction to U.S. markets later on Thursday:* European Central Bank policy decision and press conference.
Persons: Brendan McDermid, Mike Dolan, Israel, Republican Mike Johnson, Johnson, Joe Biden's, AO, Bunge, Northrop, Wang Yi, Antony Blinken, Emelia Sithole Organizations: New York Stock Exchange, REUTERS, Google, Big Tech, Nasdaq, Semiconductor, SOX, Bank of Japan, U.S . House, Republican, United Auto Workers, Ford, European, ECB, Chartered, BNP, Central Bank, Turkish Central Bank, Fed, Intel, UPS, Honeywell, Merck, Comcast, Mastercard, Capital, Energy, Mohawk, Eastman Chemical, Camden Property, AO Smith, Hasbro, Myers Squibb, Boston Scientific, Hershey, Northrop Grumman, Treasury, Foreign, U.S, Brussels Reuters Graphics Reuters, Reuters, Thomson Locations: New York City, U.S, Wall, Israel, Gaza, Philadelphia, Bank, Ukraine, China, Kansas, Bristol, Washington, Brussels
Cramer's Lightning Round: Sell Fisker
  + stars: | 2023-10-23 | by ( Julie Coleman | ) www.cnbc.com   time to read: +1 min
Stock Chart Icon Stock chart icon Fisker's year-to-date stock performance. Stock Chart Icon Stock chart icon AutoNation's year-to-date stock performance. Stock Chart Icon Stock chart icon Nu's year-to-date stock performance. Stock Chart Icon Stock chart icon Iridium's year-to-date stock performance. Stock Chart Icon Stock chart icon Bristol-Myers' year-to-date stock performance.
Persons: I'm, Petroleo, it's, We're, Myers Organizations: Petroleo, Bristol, Myers, pharma Locations: America
The company paid a dividend of $1.74 per share in late September, which included a quarterly base dividend of 50 cents per share and a variable dividend of $1.24. The acquisition, anticipated to close in January 2024, is expected to boost CIVI's free cash flow per share by 5% in 2024. In September, the company announced a quarterly dividend of 57 cents per share, payable on Nov. 1. (See Chesapeake Insider Trading Activity on TipRanks)EOG ResourcesLet's look at another energy company: EOG Resources (EOG). Based on this quarterly dividend, the annual dividend rate comes to $3.30 per share, bringing the dividend yield to 2.5%.
Persons: Paresh Dave, Wall, Civitas, Lloyd Byrne, CIVI, Byrne, TipRanks, Bristol Myers, BMY, Goldman Sachs, Chris Shibutani, Shibutani, Umang Choudhary, Choudhary, EOG, Nitin Kumar, Eagle, Kumar Organizations: Cisco Systems Inc, Civitas, Civitas Resources, Vencer Energy, Jefferies, Midland, Bristol, Bristol Myers Squibb, Mirati Therapeutics, Chesapeake Energy, Management, Chesapeake, EOG, Eagle Ford, TipRanks, Cisco Locations: San Jose , California, Denver, Midland, West Texas
One of the downsides of taking new anti-obesity medications is that patients tend to lose lean muscle mass along with body fat. "This is a major shortcoming in terms of not just quality of life for the patients who have to lose lean muscle mass, but there's actually room to improve on the weight loss and there [are] other metabolic benefits to improving your lean muscle mass ... [including] you might have better durability of weight loss." The drug is being tested in a phase 2b study alongside semaglutide to protect against loss of muscle mass. Until then, patients will need to watch what they eat and focus on exercise just as they would on any other weight loss regimen. When that occurs, muscle loss will be an even bigger issue than it is now.
Persons: Piper Sandler, Allison Bratzel, there's, Bratzel, Versanis, Eli Lilly, Eli Lilly's Mounjaro, they're, Lydia Alexander, Alexander, Sandler's Bratzel, incretins, Biohaven, Nestle, Ulf Mark Schneider, Jeff Jonas, Jonas, Stephens, Jim Salera, Atkins, Morgan Stanley, — CNBC's Michael Bloom Organizations: Wall, Nordisk's Ozempic, Obesity Medicine Association, Bristol Myers Squibb, Nestle, Gabelli, Quest, Foods Locations: Swiss
This is one of several new studies exploring ways to improve how bladder cancer is treated. “Ever since I was in med school, a metastatic bladder cancer treatment was gemcitabine and platinum. Urothelial cancer is a type of bladder cancer that begins in the urothelial cells, which line the inside of the bladder. The drug became the first therapy targeting a genetic alteration to be approved by the FDA to treat patients with the most common type of bladder cancer, metastatic urothelial cancer. “These results support nivolumab plus cisplatin-based chemo as a new standard approach for the treatment of metastatic urothelial cancer.”
Persons: vedotin, hadn’t, , Thomas Powles, ” Powles, we’ve, , Powles, Toni Choueiri, Dana, , enfortumab, ” Choueiri, drugmaker Janssen, Dr, Sanjay Gupta, nivolumab, Matthew Galsky Organizations: CNN, Society for Medical Oncology, University of London, Barts Cancer, US, Inc, Astellas Pharma, Merck, Co, Food and Drug Administration, FDA, EMA, Lank, Genitourinary Oncology, Farber Cancer Institute, ESMO, New England, of Medicine, University of Texas, Anderson Cancer Center, US Food and Drug Administration, National Library of Medicine, CNN Health, Bristol Myers Squibb, Ono Pharmaceutical Company, Cancer, The Tisch Cancer Institute Locations: Madrid, United Kingdom, United States, Europe, Mount Sinai
The central bank also doesn’t have any incentive to restrict the economy through elevated interest rates if inflation is already under control. The US central bank has raised interest rates 11 times since March 2022 to their highest level in 22 years. The US Commerce Department reports new home sales in September. The US Commerce Department reports third-quarter gross domestic product along with September figures on new durable-goods orders. The US Labor Department reports the number of new applications for jobless benefits in the week ended October 21.
Persons: Jerome Powell, ” Gregory Daco, ” Diane Swonk, Donald Trump, Colin Kaepernick’s, Bud Light’s, Elliott Gotkine, , Jeffrey Sonnenfeld, , Satya Nadella, ” Sundar Pichai, ​ ​, Sherwin, Williams, Clark, General, Hess, Rowe Price Organizations: CNN Business, Bell, DC CNN, The Commerce Department, Federal Reserve, Treasury, KPMG, BlackRock, America, Nike, Yale School of Management, Microsoft, ” Disney, Sonnenfeld, Tottenham Hotspur, Whirlpool, Verizon, General Electric, Barclays, 3M, General Motors, Spotify, Quest Diagnostics, Mobile, Boeing, General Dynamics, Old Dominion, Hilton, Meta, IBM, US Commerce Department, Mastercard, Merck, Comcast, UPS, Myers Squibb, Northrop Grumman, Valero, The Hershey Company, Amazon, Intel, European Central Bank, US Labor Department, National Association of Realtors, Exxon Mobil, Chevron, Colgate, Palmolive, Phillips, University of Michigan Locations: Washington, EY, Israel, United States, United Kingdom, London, Gaza, Kimberly, Haliburton, Old, Bristol, AbbVie
The usual suspects were to blame — rising bond yields, geopolitical tensions, and oil prices — and will hold the keys to the market this coming week. Earnings are one of the three major themes on the marquee next week, with 10 Club companies reporting. Here are the companies: Danaher (DHR), Microsoft (MSFT), Alphabet (GOOGL), Meta Platforms (META), Veralto (VLTO), Honeywell (HON), Linde (LIN), Amazon (AMZN), Ford (F) and Stanley Black & Decker (SWK). As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: , Jerome Powell, Jim Cramer, Jim, Morgan Stanley, Stanley Black, Decker, Danaher, Veralto, it's, Mark Zuckerberg, We're, Vimal Kapur, Linde, Jim Farley, Ford, FactSet, Powell, WTI, Baker Hughes, Edwards Lifesciences, Northrop, CARR, Davidson, Dr Pepper, Phillips, Jim Cramer's, Michael M Organizations: Dow Jones, Nasdaq, Economic, of New, Treasury, West Texas, Procter, Gamble, 10, Microsoft, Honeywell, Linde, LIN, Health Care, Technology, Communications Services, Google, Meta, Ford, Amazon, United Auto Workers, Atlanta, Wall Street, Hamas, Brent, Strategic Petroleum Reserve, Logitech, Verizon, General Electric, GE, RTX Corporation, Halliburton, HAL, General Motors, Dow Chemical, DOW, Xerox, Texas Instruments, F5 Networks, WM, Boeing, Fisher, Mobile, Hilton, General Dynamics, Norfolk Southern, Otis Worldwide, IBM, KLA, O'Reilly Automotive, Mattel, Whirlpool, Gross, Royal Caribbean Cruises, Hershey Company, United Parcel Service, Southwest Airlines, Altria, Northrop Grumman, Valero Energy Corp, Mastercard, Merck, Co, Myers Squibb, Newmont, Tractor Supply Company, Comcast, Seagate Technology, Boston, Hertz, Carrier, Hasbro, Harley, Intel, Grill, United States Steel, Boston Beer Company, Texas, University of Michigan, Exxon Mobil, Chevron, Charter Communications, Colgate, Palmolive, Newell Brands, Sanofi, Jim Cramer's Charitable, CNBC, Traders, New York Stock Exchange, Santiago, Getty Locations: of New York, U.S, Industrials, OpenAI, America, Venezuela, Cleveland, Norfolk, ORLY, Bristol, Brunswick, Oshkosh, New York City
Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsOct 19 (Reuters) - Bristol Myers Squibb (BMY.N) said on Thursday the injectable form of its blockbuster cancer drug Opdivo met the main goal in trial that had patients with a type of kidney cancer. "We believe this new option, given as a single injection administered in less than five minutes, could transform the treatment experience for both patients and physicians," Gina Fusaro, an executive at Bristol Myers Squibb, said. The trial also showed a non-inferior response rate to the subcutaneous drug, compared to its intravenous form. Bristol Myers now plans to discuss with regulators the next steps for submission and approval of subcutaneous injections for multiple types of cancers.
Persons: Bristol Myers, Dado Ruvic, Opdivo, Gina Fusaro, Roche, Johnson, Helen Torley, Leroy Leo, Anil D'Silva, Shinjini, Shounak Organizations: Bristol, Bristol Myers Squibb, REUTERS, Therapeutics, U.S, Thomson Locations: Bengaluru
Risky biotech M&A therapy will heal more fractures
  + stars: | 2023-10-19 | by ( Jonathan Guilford | ) www.reuters.com   time to read: +8 min
NEW YORK, Oct 19 (Reuters Breakingviews) - How can a suitor offering $1 billion see eye-to-eye with a seller asking for $2 billion? Such contingent value rights, or CVRs, are a way to get around the inherent uncertainty of an unproven drug. Its $74 billion takeover of Celgene in 2019 included a $6.4 billion payout dependent on a trio of drug approvals. There have been only 27 biotech market debuts this year, raising $2.2 billion, according to LSEG data. Given the nagging fissures in valuation perspectives, however, more dealmakers are apt to try this risky M&A therapy.
Persons: Schulman, Sidley, Bristol Myers, Myers, CVRs, Andrew Weisenfeld, IPOs, , Dan Lepanto, biopharma, Eli Lilly’s, Bristol Myers Squibb, Jeffrey Goldfarb, Sharon Lam, Streisand Neto Organizations: Reuters, Dow, Marion Laboratories, LyondellBasell Industries, Mirati Therapeutics, JPMorgan, Sanofi, Health Partners, Nasdaq Biotechnology, Reuters Graphics Reuters, Reuters Graphics, Leerink Partners, Therapeutics, Public, Bristol Myers, U.S . Food, Drug Administration, Thomson Locations: Celgene, Genzyme, U.S
CNN —Astronomers using the James Webb Space Telescope have for the first time detected tiny quartz crystals containing silica — a common mineral on Earth — within the atmosphere of a blazing hot exoplanet. An artist's concept depicts what the exoplanet WASP-17b could look like. What the quartz crystals reveal about WASP-17bWasp-17b takes 3.7 Earth days to complete one orbit around its star. Webb detected quartz crystals in the atmosphere of WASP-17b. While the clouds can drift around the planet, they likely vaporize on the hot day side, which could send the quartz particles swirling.
Persons: James Webb, Ralf Crawford, , , David Grant, Hannah Wakeford, ” Grant, Wakeford Organizations: CNN —, NASA, ESA, CSA, University of Bristol, WASP, Minerals, “ WASP
Restored Paul McCartney and Wings tour bus to be auctioned
  + stars: | 2023-10-17 | by ( ) www.reuters.com   time to read: +1 min
LONDON, Oct 17 (Reuters) - A fully restored double-decker bus used by Paul McCartney and his band Wings for a 1972 European tour is headed for auction next month, with bids expected at $200,000-300,000. Former Beatle McCartney and his late wife Linda formed the American-British rock band, Paul McCartney and Wings, known as Wings, together with drummer Denny Seiwell and guitarist Denny Laine in 1971, after the break-up of the legendary band. In the summer of 1972, they set off for the “Wings Over Europe" tour, travelling on the 1953 Bristol KSW double-decker bus, known as WNO 481. The bus, whose exterior is painted in shades of blue, red, green and yellow, with psychedelic artwork, reflecting the hippie style of the era, travelled across nine European countries on the 1972 tour. "This bus went all over south of France and Germany and Finland...just a summer of fun with the Wings band," said Nolan.
Persons: Paul McCartney, Beatle McCartney, Linda, Denny Seiwell, Denny Laine, Paul, Paul didn't, Martin Nolan, Nolan, Eric Clapton, Kurt Cobain, Marie, Louise Gumuchian, Deborah Kyvrikosaios Organizations: Wings, , Bristol KSW, Julien's, Thomson Locations: European, British, Europe, Spain, Britain, France, Germany, Finland, Nashville
Leicester claim first draw with Man Utd in WSL
  + stars: | 2023-10-15 | by ( Lori Ewing | ) www.reuters.com   time to read: +2 min
Willie Kirk's second-place side have seven points from three games, level with leaders Manchester City, who thrashed Bristol City 5-0, and also with title holders Chelsea who beat West Ham United 2-0 on Saturday. Captain Aileen Whelan struck at the far post from a freekick in the 60th minute to give Leicester a surprise lead, having frustrated their hosts for an hour. However, defender Maya Le Tissier equalised seven minutes later when she headed home Katie Zelem's corner to the delight of the home fans. Leicester have been a revelation early this campaign, unbeaten in their first three games after a 10th-place finish last season. The 30-year-old said in an Instagram post that the jersey sold out on Monday, the same day it was released.
Persons: Manchester United's Alessia Russo, Jason Cairnduff, Willie Kirk's, Captain Aileen Whelan, Maya Le Tissier, Katie Zelem's, Kirk, Hinata Miyazawa, Malard, cradling, United, Gabby George, Marc Skinner, Gabby, Mary Earps, Earps, Lori Ewing, Christian Radnedge Organizations: Soccer, League, Manchester United, Leicester City, Leigh Sports Village, Rights, Super League, Manchester City, Bristol City, Chelsea, West Ham United, United, Leicester, Nike, Thomson Locations: Leigh, Britain, Manchester, Rights MANCHESTER, England
Energetic Everton down Liverpool, Man City go top of WSL
  + stars: | 2023-10-15 | by ( ) www.reuters.com   time to read: +2 min
LIVERPOOL, England, Oct 15 (Reuters) - Liverpool's fine start to the Women's Super League season came to a shuddering halt on Sunday as Everton grabbed a 1-0 win in the Merseyside derby at Anfield, while Manchester City thrashed Bristol City 5-0 to lead the table. That result saw the Reds slip to fifth spot after City's hammering of bottom side Bristol put them top with seven points after three games, one point ahead of Liverpool. It was Russo's first league goal for the Gunners since her move from Manchester United in the close season and came in front of a crowd of more than 35,000 at the Emirates. Champions Chelsea are third on seven points after goals in each half from Sam Kerr and Erin Cuthbert gave them a comfortable 2-0 home win over West Ham United on Saturday. Reporting by Philip O'Connor; Editing by Ken FerrisOur Standards: The Thomson Reuters Trust Principles.
Persons: Megan Finnigan, Jill Roord, Bunny Shaw, Laia Alexandri, Katie McCabe, Beth Mead, Alessia Russo, Sam Kerr, Erin Cuthbert, Philip O'Connor, Ken Ferris Organizations: LIVERPOOL, Women's Super League, Everton, Anfield, Manchester City, Bristol City, Liverpool, Arsenal, Aston Villa, Reds, Bristol, City, Gunners, Manchester United, Emirates, Leicester City, Tottenham Hotspur, Brighton & Hove Albion, Champions Chelsea, West Ham United, Thomson Locations: England, Merseyside, Liverpool, Leicester
US FDA approves Pfizer's inflammatory bowel disease drug
  + stars: | 2023-10-13 | by ( ) www.reuters.com   time to read: +1 min
REUTERS/Johanna Geron/File Photo Acquire Licensing RightsOct 13 (Reuters) - The U.S. Food and Drug Administration has approved Pfizer's (PFE.N) drug to treat adults with an inflammatory bowel disease called ulcerative colitis, the company said on Friday. The decision was based on data from a late-stage study that showed a reduction in disease symptoms for some patients who took the drug, when compared with the placebo. Globally, the market for inflammatory bowel diseases is about $20 billion, making it a lucrative target for drugmakers. Analysts last year estimated that peak sales for the Pfizer drug could top $3 billion a year. Reporting by Khushi Mandowara in Bengaluru; Editing by Arun Koyyur and Devika SyamnathOur Standards: The Thomson Reuters Trust Principles.
Persons: Johanna Geron, Velsipity, Bristol Myers, Khushi, Arun Koyyur Organizations: Pfizer, REUTERS, U.S . Food, Drug Administration, Arena Pharmaceuticals, Bristol, drugmakers, Thomson Locations: Puurs, Belgium, U.S, United States, Bengaluru
Total: 25